The chief executive of pharmaceutical firm has said the global supply chain could be drastically affected ahead of President Donald Trump’s tariff announcement.
Gareth Sheridan, of Nutriband, said his firm makes important drugs including chemotherapy treatments, antibiotics and pain medication in Ireland.
He added that a quarter of Americans had “foregone treatment” because of the cost and that could rise by 25%, becoming “an extreme burden on the patient”.
“If you have a 25% hike on chemotherapy and you can’t afford your treatment anymore what’s the alternative?” he said.
“Ultimately, people are going to die and they’re going to die because they can’t afford to live.”
You can read more on this story here.
